speaker-icon

Latest Posts

anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More
Kittu-Press-Release

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Pharma Forum

This year, the event looked at “Medicine to Corona – New Technologies for the Healthcare Industry.”

Speakers:

– Prof. Dr. Dr. med. Juergen Scheele – Chief Medical Officer

– Dr. med Werner Seiz – SVP Translational Services

– Dr. Bruno Duarte Moreira – SVP Commercial Services

– Mr. Vatsal Agarwal –  SVP Real World Data & Analytics

– Ms. Carina Schulte – Head of Marketing & Communications

Date: March 23, 2022

Venue: Kurhauskolonnade, Wiesbaden Germany